Trademarkia Logo

Canada

C$
FULBRYT
REGISTERED

on 16 Aug 2024

Last Applicant/ Owned by

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

55218 Ingelheim

DE

Serial Number

2146512 filed on 20th Sept 2021

Registration Number

TMA1250831 registered on 16th Aug 2024

Registration expiry Date

20th Sept 2031

Correspondent Address

MARKS & CLERK

33 Yonge Street, Suite 300Toronto

ONTARIO

CA

M5E1G4

FULBRYT

Trademark usage description

pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, liver diseases, pancreas diseases, digestive system disorders, gastrointestinal diseases and disorders, obesity; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs, namely, vascular diseases, hematology, blood disorders; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders, musculoskeletal diseases and disorders, central nervous system diseases and disorders, peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of genitourinary system diseases, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the prevention and treatment of the respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues, namely, rashes, sores, psoriasis, eczema; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections, namely, antibiotics, anti-infectives, antivirals; pharmaceutical preparations for the prevention and treatment of oncological diseases; pharmaceutical preparations for the prevention and treatment of auto-immune diseases and disorders; cell based immune therapeutics for treatment of cancer; cell based immune therapeutics for treatment of immunological diseases, namely, autoimmune diseases and disorders; cell based immune therapeutics for treatment of infectious diseases, namely viral infections.


Classification kind code

11

Mark Details


Serial Number

2146512

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 24th Apr 2024
Agent Changed
Submitted for opposition 22
on 15th Feb 2023
Search Recorded
Submitted for opposition 20
on 15th Feb 2023
Examiner's First Report
Submitted for opposition 223
on 15th Feb 2023
Total Provisional Refusal
Submitted for opposition 256
on 12th Sept 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 11th Nov 2021
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 10th Nov 2021
Created
Submitted for opposition 31
on 10th Nov 2021
Formalized
Submitted for opposition 30
on 20th Sept 2021
Filed
Submitted for opposition 228
on 20th Sept 2021
International Registration